Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.

Not Recruiting

Trial ID: NCT01932060


Although prior dose-finding studies have investigated the optimal bolus dose of oxytocin to initiate adequate uterine tone, it is unclear what oxytocin infusion regimen is required to maintain adequate uterine tone after delivery. The study investigators aim to compare two different infusion rates of oxytocin to assess the optimal infusion regimen for reducing blood loss in women undergoing elective Cesarean delivery.

Official Title

Effects of Different Oxytocin Infusions on Blood Loss and Postpartum Hemoglobin Values in Patients Undergoing Elective Cesarean Delivery

Stanford Investigator(s)

Alex Butwick
Alex Butwick

Professor of Anesthesiology, Perioperative and Pain Medicine (OB)


Inclusion Criteria:

   - Healthy pregnant patients with uncomplicated pregnancies:

   - ASA (American Association of Anesthesiologists) class 1 or 2 patients.

   - Singleton pregnancies.

Exclusion Criteria:

   - ASA class 3 or 4 patients.

   - Known drug allergy to intravenous oxytocin.

   - Significant medical or obstetric disease.

   - Known uterine abnormality.

   - Known placental abnormality.


drug: Oxytocin Infusion

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Alexander J Butwick, F.R.C.A